✦ LIBER ✦

A phase 1 study of OSI-930 in combination with erlotinib in patients with advanced solid tumours

✍ Scribed by Macpherson, I.R.; Poondru, S.; Simon, G.R.; Gedrich, R.; Brock, K.; Hopkins, C.A.; Stewart, K.; Stephens, A.; Evans, T.R.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of olaparib in combination

✍ Del Conte, G; Sessa, C; von Moos, R; Viganò, L; Digena, T; Locatelli, A; Gallera 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 299 KB

A phase I, dose-finding study of sunitin

✍ Boven, E; Massard, C; Armand, J P; Tillier, C; Hartog, V; Brega, N M; Countourio 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 394 KB

A phase I study of OSI-461 in combinatio

✍ Lee P. Resta; Roberto Pili; Mario A. Eisenberger; Avery Spitz; Serina King; Jenn 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 341 KB

5067 POSTER A Phase 1 Study of Neratinib

✍ Onozawa, Y.; Watanabe, J.; Yamamoto, N.; Boku, N.; Suzuki, M.; Takenaka, N.; Ito 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Phase I/II study of DHA–paclitaxel in co

✍ Harries, M; O'Donnell, A; Scurr, M; Reade, S; Cole, C; Judson, I; Greystoke, A; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

417 POSTER Phase I study of E7389/Gemcit

✍ R. Goel; L. Vidal; S. Welch; S. Laurie; L. Siu; D. Jonker; R. Srinivasan; L. Wan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB